# FDA Inspection 1048379 - GREFI - April 05, 2018

Source: https://www.keypedia.com/records/fda_inspections/grefi/63befdfa-b892-4a51-a280-f62023950dfc
Source feed: FDA_Inspections

> FDA Inspection 1048379 for GREFI on April 05, 2018. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1048379
- Company Name: GREFI
- Inspection Date: 2018-04-05
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1145211 - 2021-06-14](https://www.keypedia.com/records/fda_inspections/grefi/93e1b0cd-848e-422b-8ec3-02bddcd1f424)
- [FDA Inspection 1145211 - 2021-06-14](https://www.keypedia.com/records/fda_inspections/grefi/eb7626ec-a116-45d8-bc40-860396419a66)
- [FDA Inspection 1101917 - 2019-10-01](https://www.keypedia.com/records/fda_inspections/grefi/f0bd9547-c9d4-4513-bd6e-1d85bd384b25)
- [FDA Inspection 1101917 - 2019-10-01](https://www.keypedia.com/records/fda_inspections/grefi/265d8941-3077-4ba0-94b4-3b34e4d06558)
- [FDA Inspection 1048379 - 2018-04-05](https://www.keypedia.com/records/fda_inspections/grefi/3f883758-b0b6-4f36-b2f4-00c3632e3a7e)

Company: https://www.keypedia.com/companies/grefi/83794621-4501-476a-b8da-1193825d6326

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d